北米の心臓モニタリングおよび心拍リズム管理デバイス市場 – 業界動向と2030年までの予測

Get Exclusive Sample PDF of this Report Here

北米の心臓モニタリングおよび心拍リズム管理デバイス市場の分析と規模

北米の心臓モニタリングおよび心拍リズム管理デバイス市場は、さまざまな要因により大幅な成長を遂げています。心血管疾患の罹患率の上昇、高齢化人口の増加、医療技術の進歩により、この地域では心臓モニタリングおよび心拍リズム管理デバイスの需要が高まっています。さらに、心臓病の早期発見と管理に関する意識の高まりと、有利な償還方針が相まって、市場の拡大を後押ししています。                                

Data Bridge Market Researchは、2022年に22億4,587万米ドルであった心臓モニタリングおよび心調律管理デバイス市場は、2030年までに35億6,757万米ドルに急増し、予測期間中に3.90％のCAGRを達成すると分析しています。これは、市場価値を示しています。心臓リズムモニタリング用のECGデバイスの需要が高まっているため、「ECGデバイス」が心臓モニタリングおよび心調律管理デバイス市場の製品セグメントを支配しています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

北米の心臓モニタリングおよび心拍リズム管理デバイス市場の範囲とセグメンテーション

Get Exclusive Sample PDF of this Report Here

市場の定義

心臓モニターは、ストレス波形の形で心臓の電気的活動を反映する機器として定義されます。心電図検査を通じて、心臓の定常的および一時的な運動を追跡します。心臓のソフトで適切な機能のために、心臓モニターは心臓チャンバー内に配置されます。これらのデバイスは、心房雑音、心房細動の兆候、心房細動、心不全、冠状動脈虚血、心臓組織への酸素供給不足、薬物の影響、特定の遺伝子異常など、主要な心臓疾患の治療に使用されます。            

北米の心臓モニタリングおよび心拍リズム管理デバイス市場の動向

ドライバー

• 心血管疾患の罹患率の増加

心不全、不整脈、冠動脈疾患などの心血管疾患の発生率の上昇は、心臓モニタリングおよび心拍リズム管理デバイス市場の主な推進力となっています。高齢化人口の増加、座りがちな生活習慣、不健康な食習慣が心血管疾患の負担増加に寄与し、モニタリングおよび管理デバイスの需要が高まっています。

• 心臓の健康に対する意識の向上と積極的なアプローチ

心臓疾患の早期発見と予防的管理の重要性に対する認識が高まっています。人々は心臓の健康維持を意識するようになり、予防策と定期的なモニタリングを求めています。消費者行動のこの変化により、心臓モニタリング デバイスとリズム管理ソリューションの需要が高まっています。

機会

• 在宅および遠隔監視ソリューションの需要増加

心臓モニタリングおよび心拍リズム管理デバイス市場では、在宅および遠隔モニタリング ソリューションへの傾向が高まっています。患者と医療提供者は、自宅で快適に心臓の健康をモニタリングすることの利点をますます認識しています。これは、企業にとって、ユーザー フレンドリーでポータブルであり、医療専門家にリアルタイム データを送信して心臓の状態を積極的に管理できるデバイスを開発して販売する機会となります。

• Integration of artificial intelligence (AI) and machine learning (ML)

The integration of AI and ML algorithms in cardiac monitoring and rhythm management devices offers significant opportunities for the market. These technologies can analyze large volumes of patient data, identify patterns, and provide predictive analytics for early detection of cardiac abnormalities. AI-driven algorithms can also assist in personalized treatment recommendations and decision-making, improving patient outcomes. Companies that leverage AI and ML capabilities to enhance the accuracy and efficiency of cardiac monitoring and rhythm management devices have a competitive advantage in the market.

Restraints

• High cost of devices and limited healthcare budgets

The cost of cardiac monitoring and cardiac rhythm management devices can be significant, especially for advanced and innovative technologies. This high cost may pose a restraint to market growth, particularly in regions with limited healthcare budgets. Healthcare providers and patients may face challenges in accessing and affording these devices, impacting their adoption rates and overall market expansion.

• Stringent regulatory requirements

The cardiac monitoring and cardiac rhythm management devices market is subject to stringent regulatory requirements, including product approvals and certifications. Obtaining regulatory approvals can be time-consuming and costly, which can hinder the introduction of new devices into the market. Compliance with regulatory standards, such as those set by the FDA in the United States, requires rigorous testing and documentation, which can pose challenges for smaller manufacturers or companies with limited resources.

Challenges

• Intense competition and market saturation

The cardiac monitoring and cardiac rhythm management devices market is highly competitive, with numerous companies vying for market share. This intense competition can make it challenging for new entrants to establish a foothold and for existing players to maintain their market position. The market may also become saturated with similar products, leading to price pressures and reduced profit margins for companies.

• Data privacy and security concerns

Cardiac monitoring and rhythm management devices generate a vast amount of sensitive patient data. Ensuring the privacy and security of this data is a significant challenge for the market. Healthcare organizations and device manufacturers need to implement robust data protection measures to prevent unauthorized access, breaches, and potential misuse of patient information. Compliance with data privacy regulations, such as HIPAA in the United States, adds an additional layer of complexity and responsibility.

This cardiac monitoring and cardiac rhythm management devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiac monitoring and cardiac rhythm management devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In November 2022, Boston Scientific the LUX-Dx Insertable Cardiac Monitor (ICM) System, a long-term diagnostic device inserted under the skin of patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke, and syncope in Europe.
• In October 2022, Medtronic PLC received the United States FDA approval for extended labeling of a cardiac lead that uses the heart's natural electrical system to deliver therapy to patients while avoiding complications.

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Scope

The cardiac monitoring and cardiac rhythm management devices market is segmented on the basis of product and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• ECG devices

Type

• Resting ECG systems
• Stress ECG systems
• Holter monitors

Lead type

• Single-lead ECG leadwires
• ECG leadwires
• Others
• Implantable loop recorders
• Cardiac output monitoring (COM) devices
• Minimally invasive COM devices
• Noninvasive COM devices
• Event monitors

Type

• Pre-symptom (Memory Loop)
• Post-symptom event monitor

Technology

• Auto detect monitors
• Manual event monitor
• Mobile cardiac telemetry monitoring (MCT/MCOT)
• Smart wearable ECG monitors
• Defibrillators

Implantable cardioverter defibrillators

• Transvenous implantable cardioverter defibrillators
• Biventricular ICDS/cardiac resynchronization therapy defibrillators
• Dual-chamber ICDS
• Single-chamber ICDS
• Subcutaneous implantable cardioverter defibrillators

External defibrillators

• Automated external defibrillators
• Fully automated external defibrillators
• Semi-automated external defibrillators
• Pacemakers

Type

• Dual-chamber pacemakers
• Single-chamber pacemakers
• Implantability
• Implantable pacemakers
• External pacemakers
• Cardiac resynchronization therapy (CRT) devices
• CRT-P (CRT with pacemaker function)
• CRT-D (CRT with pacemaker and ICD function)

End-User

• Hospitals
• Home and ambulatory care settings
• Others

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Regional Analysis/Insights

The cardiac monitoring and cardiac rhythm management devices market is analysed, and market size insights and trends are provided by country, product and end-user, as referenced above.

The countries covered in the cardiac monitoring and cardiac rhythm management devices market report are U.S., Canada and Mexico in North America.

The U.S. is expected to dominate North America cardiac monitoring and cardiac rhythm management devices market due to Technical advancement in the field of cardiac.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed bAse and New Technology Penetration

The cardiac monitoring and cardiac rhythm management devices market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kind of products for cardiac monitoring and cardiac rhythm management devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cardiac monitoring and cardiac rhythm management devices market. The data is available for the historic period 2015-2020.

Competitive Landscape and North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Share Analysis

The cardiac monitoring and cardiac rhythm management devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cardiac monitoring and cardiac rhythm management devices market.

Some of the major players operating in the cardiac monitoring and cardiac rhythm management devices market are:

• GENERAL ELECTRIC (U.S.)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• SCHILLER (Switzerland)
• Koninklijke Philips N.V. (Netherlands)
• Biotronik SE & Co., KG (Germany)
• Hill-Rom Services, Inc. (U.S.)
• ABIOMED (U.S.)
• NIHON KOHDEN CORPORATION (Japan)
• ReliantHeart Inc. (U.S.)
• 3M (U.S.)
• Berlin Heart (Germany)
• Jarvik Heart, Inc. (U.S.)
• Stryker (U.S.)
• 旭化成株式会社（日本）
• リヴァノヴァ PLC (英国)
• BioTelemetry, Inc. (米国)
• OSI Systems, Inc. (米国)
• ミッドマーク社（米国）
• ZOLLメディカルコーポレーション（米国）
• エドワーズライフサイエンスコーポレーション（米国）
• Getimge AB (スウェーデン)

SKU-1850